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Purpose: An established link exists between overactive bladder (OAB) syndrome and impaired sleep. However, earlier re-
search on this subject only focused on the general population, and certain patient subgroups have not been examined ade-
quately. Depressed patients constitute a unique population because of a possible bidirectional relationship between OAB and 
depression. Thus, we investigated the association between OAB symptoms and sleep quality in patients with depression.
Methods: In this prospective, cross-sectional study, we analyzed data on depression, sleep quality, and OAB symptoms from 
depressed patients treated at our department of adult psychiatry. Data were collected with the Hamilton Rating Scale for De-
pression, the Holland Sleep Disorders Questionnaire, the Athens Insomnia Scale, and the OAB Module of the International 
Consultation on Incontinence Questionnaire.
Results: In total, 102 patients treated for depression were enrolled. Thirteen patients (12.7%) met the diagnostic threshold of 
OAB with the International Consultation on Incontinence Questionnaire OAB Module. Patients with depression and con-
comitant OAB had significantly higher scores on the Holland Sleep Disorders Questionnaire than patients classified as non-
OAB (P<0.01). OAB patients also had a higher risk of insomnia relative to non-OAB individuals (P<0.05). In addition, the 
relationship between OAB symptoms and sleep quality in patients with depression was independent from age and sex.
Conclusions: In our cohort composed exclusively of individuals treated for depression, OAB symptoms were present in a sig-
nificant proportion of patients, and OAB negatively affected sleep quality. Therefore, we recommend that OAB symptoms 
should be assessed collectively in patients with depression.
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INTRODUCTION
Overactive bladder (OAB) is a bladder-centric syndrome that 
consists of urinary urgency with or without urge urinary incon-
tinence, often accompanied by frequency and nocturia [1]. The 
prevalence of OAB ranges from 7% to 27% in men and 9% to 
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43% in women; its prevalence tends to increase with age [2]. 
OAB-induced impairment of quality of life has been well docu-
mented, and OAB weakens physical, emotional, social, and 
mental functioning [3]. OAB may lead to isolation, embarrass-
ment, reduced contact with family and friends, loss of confi-
dence or motivation, sexual dysfunction, and hopelessness. As 
a result, OAB may advance some symptoms of depression.
Sleep is a major component of mental and physical health [4]. 
Sleep problems were found to be associated with poor social in-
teraction, diminished work productivity and work quality, and 
lower overall quality of life. Numerous studies have linked low-
er urinary tract symptoms to sleep disturbance [5-7]. Both stor-
age and voiding lower urinary tract symptoms were found to be 
independent predictors of sleep dysfunction. However, research 
has been limited regarding the possible correlation between 
OAB and sleep disorders [8,9], although the relationship be-
tween nocturia, an OAB symptom, and sleep problems has 
been examined extensively [10,11]. The relationship between 
OAB and sleep complaints, therefore, is not well understood 
and warrants additional investigation [12]. Importantly, thus 
far, investigators have examined only the general population 
(i.e., mentally healthy persons without diagnoses of depression 
or other psychiatric disorders). The association between OAB 
and sleep quality has not been assessed in detail for most spe-
cific patient subpopulations, although clinicians could better 
serve some of their patients if they were armed with informa-
tion about the possible association between urinary tract symp-
toms, including OAB, and sleep quality [13].
Patients with depression represent a uniquely important 
population because of a possible bidirectional relationship be-
tween OAB and depression [14,15]. This bidirectional relation-
ship should encourage the multidisciplinary management of 
patients with depression coordinated by psychiatrists and urol-
ogists. However, until now, the medical community has not in-
vestigated the impact of OAB on sleep quality in patients with 
depression. Even though current recommendations underscore 
the need for sleep assessment of OAB patients, it is still un-
known whether OAB is correlated with sleep quality in patients 
treated for depression. This data vacuum may lead to a hypoth-
esis that the coexistence of OAB and sleep dysfunction in de-
pressed patients might be more complex, underreported, and 
undertreated. These absent data are necessary to provide a 
more comprehensive understanding of the clinical workup and 
integrated care that depressed patients need. Moreover, the 
sleep quality of patients with depression may be independently 
decreased by depression itself. Thus, the aim of this study was 
to investigate connections between OAB and sleep quality in 
patients with depression. We hypothesized that patients with 
depression who reported OAB symptoms experienced greater 
sleep impairment than patients with depression who did not 
have OAB symptoms.
MATERIALS AND METHODS
Between 2014 and 2015, adult patients treated in our outpatient 
and inpatient department of adult psychiatry were prospective-
ly recruited for this study. We assessed the severity of their de-
pression, sleep disturbances, and OAB symptoms. All the in-
cluded patients met both the Diagnostic and Statistical Manual 
of Mental Disorders, Fifth Edition (DSM-5) and International 
Classification of Diseases, 10th Revision (ICD-10) criteria for 
depression, and psychiatrists established the diagnoses of all 
patients. The following demographic data were considered a 
priori: age, sex, education, employment status, relationship, re-
cent hospitalizations due to depression, familial history of de-
pression, and depression medications.
Instruments
The Hamilton Rating Scale for Depression (HRSD), also known 
as the Hamilton Depression Rating Scale, was used to classify 
depression severity. The HRSD was designed to be adminis-
tered by clinicians after a structured or unstructured patient in-
terview to determine their symptoms [16]. The HRSD has been 
used in many key studies of depression and treatment, and 
consists of 17 questions with a total score between 0 and 54. For 
this study, patients were classified as being in remission - no de-
pression (0–7), having mild depression (8–16), having moder-
ate depression (17–23), or having severe depression (≥24). Psy-
chiatrists completed the HRSD questionnaire.
We used the Holland Sleep Disorders Questionnaire (HSDQ) 
to assess sleep quality. The HSDQ is a clinically validated in-
strument composed of International Classification of Sleep 
Disorders clusters of sleep complaints/symptom descriptions; 
the HSDQ enables a clinician to determine whether the respon-
dent meets the diagnostic criterion/criteria for 1 or more sleep 
disorders [17]. The HSDQ has 32 questions and a total score 
between 32 and 160. In this research, we focused on the contin-
uous variable of general sleep disorder from the HSDQ. Pa-
tients self-administered the questionnaire.
We evaluated insomnia using the Athens Insomnia Scale 
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(AIS). The AIS is a self-assessment psychometric instrument 
designed for quantifying sleep difficulty based on the ICD-10 
criteria [18]. Sleep difficulty is measured using 8 factors, among 
which the first 5 factors are related to nocturnal sleep and the 
final 3 aspects are related to daytime dysfunction. The first 5 
factors pertain to sleep induction, awakening during the night, 
final awakening, total sleep duration, and sleep quality. The last 
3 refer to well-being, functioning capacity, and daytime sleepi-
ness. The factors are rated on a 0–3 scale and a total score be-
tween 0 and 24. A cutoff score of ≥6 on the AIS is equated to a 
diagnosis of insomnia [19].
The International Consultation on Incontinence Question-
naire Overactive Bladder Module (ICIQ-OAB) is a brief yet 
comprehensive instrument for evaluating OAB. It is a measure 
that assesses the impact of urinary frequency, urgency, urge in-
continence, and nocturia [20]. The ICIQ-OAB consists of 8 
questions with a total score between 0 and 54. An ICIQ-OAB 
score greater than or equal to 28 has been considered diagnos-
tic for OAB in multiple studies [21]. We also used this threshold 
in our study, and we divided our patients into 2 groups: OAB 
(ICIQ-OAB score greater than or equal to 28) and non-OAB 
(ICIQ-OAB score less than 28). The instrument was self-ad-
ministered by patients.
Statistics
Means, standard deviations, medians, minimum and maxi-
mum values (range), and 95% confidence intervals were used 
to present descriptive results for continuous data, and counts 
and percentages were used for discrete data. The Shapiro-Wilk 
test was used to analyze distribution and the Leven (Brown-
Forsythe) test was used to investigate the hypothesis of equal 
variance. To evaluate differences between 2 groups (unrelated 
variable model), we used the Student t-test (or the Welch test in 
the absence of variance homogeneity) or the Mann-Whitney 
U-test (if the Student t-test could not be applied or for variables 
measured on an ordinal scale). Regression analysis was used to 
investigate the effect of OAB on sleep quality in patients with 
depression regardless of age and sex. To establish links between 
variables, and to assess the strength and direction of those rela-
tionships, correlation analysis was conducted by calculating 
Pearson and/or Spearman correlation coefficients. Statistical 
significance was considered to be present if the P-value was 
<0.05. Data analysis was conducted with Statistica ver. 12.0 
(StatSoft Inc., 2014, Tulsa, OK, USA).
RESULTS
Demographic and Clinical Characteristics
Initially, 106 subjects were enrolled; 4 patients failed to com-
plete the questionnaires, leaving 102 patients to be analyzed. 
The mean age of our cohort was 46.1 years (range, 20–67 years). 
There were more women than men. Most of the 102 patients 
were employed, had attained higher education, and were in sta-
ble relationships based on patients’ perceptions (Table 1).
The mean number of hospitalizations related to depression 
was 2.4 (range, 0–20). The mean time between diagnosis of de-
pression and inclusion in the study was 10.7 years. We analyzed 
the familial history of depression in 31 individuals. Most pa-
tients were being treated with selective serotonin reuptake in-
hibitors and serotonin norepinephrine reuptake inhibitors (Ta-
ble 1). Only 6 patients were taking medications to aid with sleep 
(zolpidem or zopiclone); their demographic and clinical char-
acteristics were not statistically significantly different from 
those of other patients. Some individuals had concomitant anx-
iety (n=19), personality (n=4), obsessive-compulsive (n=3), 
and eating (n =3) disorders. All these patients met specific 
ICD-10 criteria for their specific concomitant disorders.
Instrument Scores
The mean score of the HRSD questionnaire in our study was 
15.9 (range, 1–32), and most of our patients experienced mild 
depression (n=37), followed by moderate depression (n=29), 
severe depression (n=20), and remission (n=16). The mean 
HSDQ score of our cohort was 77.4 (range, 32–146). The mean 
score of the AIS was 11.3 (range, 0–24), and 82 out of 102 pa-
tients had a score of ≥6 points (i.e., diagnostic for insomnia).
The mean score of the ICIQ-OAB instrument was 10.8 (range, 
0–55); 13 patients (12.7%) met the threshold of 28 points that 
was diagnostic for OAB. Although OAB symptoms tended to 
be more prevalent in women than in men, there were no statis-
tically significant differences between OAB and non-OAB pa-
tients in terms of age, sex, and depression severity. Table 2 pres-
ents detailed a comparison of the characteristics of the 2 study 
groups.
Correlations
We found statistically significant correlations between depres-
sion severity and sleep quality in the studied patients (Table 3). 
Patients with moderate or severe depression had higher HSDQ 
scores than those who were in remission or had mild depres-
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sion (P=0.0004). Similarly, patients with moderate or severe 
depression had significantly higher overall AIS scores than 
those who were in remission or had mild depression (P = 
0.0015). In addition, patients with moderate or severe depres-
sion had higher risks of insomnia (i.e., at least 6 points on the 
AIS) than patients in remission or with mild depression (P= 
0.0027).
We also found statistically significant correlations between 
OAB symptoms and sleep quality (Table 4). Depressed patients 
with at least 28 points on the ICIQ-OAB had higher HSDQ 
scores than those classified as non-OAB (P=0.003). OAB symp-
toms were also correlated with insomnia. OAB patients had a 
higher risk of insomnia (i.e., higher AIS scores) than non-OAB 
individuals (P=0.0192). In addition, 12 of 13 patients (92.3%) 
with OAB met the diagnostic threshold of insomnia as defined 
by the AIS (i.e., an AIS score ≥6), whereas 67 out of 89 (75.3%) 
non-OAB patients met the criteria (P=0.034).
Post hoc tests to investigate specific items of the ICIQ-OAB 
showed that nocturia (questions #3 and #4 of the ICIQ-OAB) 
had the strongest effect on sleep quality and insomnia of the in-
cluded patients. Having at least 3 episodes per night of nocturia 
was associated with significantly higher HSDQ scores and AIS 
scores. The correlations between sleep quality/insomnia and 
ICIQ-OAB questionnaire questions are presented in detail in 
Table 5. Notably, question #1 (number of daily micturitions) 
had no or minimal effect on the quality of sleep or insomnia 
(weak correlation or no correlation). We did not find statistical-
ly significant associations between sleep quality, OAB symp-
toms, and the psychiatric medications that were used by our 
cohort.
Table 1. Demographic characteristics and drugs used by the in-
cluded patients
Specification No. (%)














Stable relationship/marriage 73 (71.6)






























SNRIs, serotonin norepinephrine reuptake inhibitors; SSRIs, selective 
serotonin reuptake inhibitors; TCAs, tricyclic antidepressants; NaSSAs, 
noradrenergic and specific serotonergic antidepressants; SARIs, sero-
tonin antagonist and reuptake inhibitors. 
Other antidepressants: tianeptine, norepinephrine and dopamine reup-
take inhibitors, norepinephrine reuptake inhibitors, reversible mono-
amine oxidase inhibitor, agomelatine. Other neuroleptics: risperidone, 
clozapine, amisulpride.
Table 1. Continued
(Continued to the next page)
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Table 2. Comparative characteristic of patients without OAB symptoms (ICIQ-OAB score <28, nNon-OAB group) and patients with 
OAB symptoms (ICIQ-OAB score ≥28, OAB group) in terms of sex, age, and severity of depression
Variable Non-OAB group OAB group P-value
Sex, n (%) 0.0570‡
Women 49 (55.1) 10 (76.9)
Men 40 (44.9) 3 (23.1)
Age (yr) 0.3553†
Mean±SD 45.9±11.1 47.8±13.4
Median (range) 47.0 (20.0–67.0) 52.5 (24.0–61.0)
95% CI (43.6–48.2) (39.3–56.4)
Age group (yr), n (%) 0.6920‡
20–30 10 (11.1) 2 (16.7)
31–40 16 (17.8) 1 (8.3)
41–50 27 (30.0) 2 (16.7)
51–60 32 (35.6) 6 (50.0)
>60 5 (5.6) 1 (8.3)
HRSD 0.5749†
Mean±SD 18.0±10.4 15.8±9.3
Median (range) 18.0 (0.0–52.0) 16.0 (2.0–31.0)
95% CI (15.8–20.2) (9.8–21.7)
HRSD (category), n (%) 0.9105‡
Remission/no depression 15 (16.7) 3 (25.0)
Mild depression 25 (27.8) 3 (25.0)
Moderate depression 27 (30.0) 3 (25.0)
Severe depression 23 (25.6) 3 (25.0)
OAB, overactive bladder; ICIQ-OAB, International Consultation on Incontinence Questionnaire Overactive Bladder Module; SD, standard devia-
tion; CI, confidence interval; HRSD, Hamilton Rating Scale for Depression.  
†Mann-Whitney U-test. ‡Chi-square test.
Table 3. Comparative characteristics of patients with no depression or mild depression (HRSD score 0–16, group A) and patients with 
moderate or severe depression (HRSD score ≥17, group B) in terms of sleep quality (based on the HSDQ) and insomnia (based on 
the AIS)
Variable Group A Group B P-value
HSDQ 0.0004†
Mean±SD 69.2±28.5 84.2±19.2
Median (range) 68.5 (32.0–146.0) 82.0 (39.0–134.0)
95% CI (60.7–77.6) (79.1–89.4)
AIS score, n (%) 0.0027‡
0-5 15 (32.6) 5 (8.9)
≥6 31 (67.4) 51 (91.1)
AIS overall score 0.0015†
Mean±SD 9.3±6.2 13.0±4.8
Median (range) 8.0 (0.0–24.0) 13.5 (3.0–24.0)
95% CI (7.4–11.1) (11.7–14.3)
HRSD, Hamilton Rating Scale for Depression; HSDQ, Holland Sleep Disorders Questionnaire; AIS, Athens Insomnia Scale; SD, standard deviation; 
CI, confidence interval.
†Mann-Whitney U-test. ‡Chi-square test.
64    www.einj.org
Przydacz, et al.  •  OAB and Sleep in Depressed PatientsINJ
Int Neurourol J  March 31, 2021
Regression Analysis
As presented in Table 6, we used regression analysis to investi-
gate the effect of depression severity and OAB on sleep quality 
in depressed patients regardless of age and sex. We showed that 
depression severity affected sleep quality. Patients with no de-
pression or mild depression (HRSD, 0–16) had better sleep 
quality than patients with moderate or severe depression 
(HRSD≥17). Further, the severity of OAB symptoms assessed 
with the ICIQ-OAB was associated with decreased sleep quali-
ty; an ICIQ-OAB score of 0–27 predicted better sleep quality, 
whereas an ICIQ-OAB score of ≥28 (i.e., diagnostic of OAB) 
predicted worse sleep quality.
DISCUSSION
Patients with lower urinary tract symptoms, including OAB, 
are thought to experience higher rates of sleep disturbance than 
the general population. Our study was the first to analyze the 
Table 4. Comparative characteristic of patients without OAB symptoms (ICIQ-OAB score <28, non-OAB group) and patients with 
OAB symptoms (ICIQ-OAB score ≥28, OAB group) in terms of HSDQ and AIS scores
Variable Non-OAB group OAB group P-value
HSDQ 0.0003†
Mean±SD 75.0±23.6 102.1±19.9
Median (range) 76.0 (32.0–146.0) 102.0 (74.0–139.0)
95% CI (70.0–80.0) (89.4–114.8)
AIS
Mean±SD 11.1±5.7 14.8±4.9 0.0192†
Median (range) 11.0 (0.0–24.0) 16.5 (4.0–20.0)
95% CI (9.8;12.3) (11.6;17.9)
OAB, overactive bladder; ICIQ-OAB, International Consultation on Incontinence Questionnaire Overactive Bladder Module; SD, standard devia-
tion; CI, confidence interval; HSDQ, Holland Sleep Disorders Questionnaire; AIS, Athens Insomnia Scale.
†Mann-Whitney U-test.
Table 5. Correlations between sleep quality/insomnia and ICIQ-OAB questionnaire questions
Question number and content
Sleep quality (HSDQ) Insomnia (AIS)
R P-value R P-value
Q1.  How often do you pass urine during the day?  
(0) 1 to 6 times; (1) 7 to 8 times; (2) 9 to 10 times; (3) 11 to 12 times; (4) 13 or more times
0.17 0.0970 0.25 0.0126
Q2.  How much does this bother you?  
Likert-like scale between 0 (not at all) and 10 (a great deal)
0.43 0.0001 0.32 0.0009
Q3.  During the night, how many times do you have to get up to urinate, on average?  
(0) none; (1) one; (2) two; (3) three; (4) four or more
0.57 0.0001 0.38 0.0001
Q4.  How much does this bother you?  
Likert-like scale between 0 (not at all) and 10 (a great deal)
0.62 0.0001 0.39 0.0001
Q5.  Do you have to rush to the toilet to urinate?  
(0) never; (1) occasionally; (2) sometimes; (3) most of the time; (4) all of the time
0.50 0.0001 0.33 0.0006
Q6.  How much does this bother you?  
Likert-like scale between 0 (not at all) and 10 (a great deal)
0.51 0.0001 0.34 0.0005
Q7.  Does urine leak before you can get to the toilet?  
(0) never; (1) occasionally; (2) sometimes; (3) most of the time; (4) all of the time
0.38 0.0001 0.23 0.0180
Q8.  How much does this bother you?  
Likert-like scale between 0 (not at all) and 10 (a great deal)
0.43 0.0001 0.27 0.0052
ICIQ-OAB, International Consultation on Incontinence Questionnaire Overactive Bladder Module; HSDQ, Holland Sleep Disorders Question-
naire; AIS, Athens Insomnia Scale; R, correlation coefficient.
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ment of this patient group, particularly by cooperation between 
psychiatrists and urologists, should be a priority among health-
care professionals.
A strength of this study was the use of validated scales to as-
sess depression severity, sleep quality, and OAB symptoms. 
These instruments were unlikely to cause under- or overreport-
ing of urological and psychiatric symptoms and sleep problems. 
The use of 4 different reliable questionnaires, including 2 inde-
pendent instruments for sleep quality assessment, provided ac-
curate results. Unlike our analysis, some prior investigations 
that reported correlations between OAB and sleep in the gener-
al population did not use validated questionnaires [25,26]. It is 
strongly recommended to collectively assess OAB symptoms 
with appropriate instruments [27].
Another strength of our study was its analysis of a homoge-
neous group of patients with depression, all of whom met the 
DSM-5 and ICD-10 criteria for depression. In all cases, psychi-
atrists confirmed the diagnoses. Further, all were treated for de-
pression. The study results, therefore, clearly showed the rela-
tionship between sleep quality and OAB symptoms in this spe-
cific patient group.
In the literature, a link between sleep quality and OAB has 
been reported. Ge et al. [8], in their cross-sectional analysis of 
51 OAB patients and 30 age-matched controls, showed that 
sleep disturbances were associated with more severe OAB 
symptoms and poorer psychosocial health. Savoie et al. [9], in a 
prospective study of 161 women, demonstrated that OAB pa-
tients had high rates of poor sleep quality and sleep disruption, 
even in the absence of nocturnal bladder symptoms. Similarly, 
several epidemiological studies have presented a link between 
OAB and depressive symptoms, and they have even suggested a 
bidirectional nature of this relationship. The largest epidemio-
logical investigations of lower urinary tract symptoms and OAB 
(NOBLE, EPIC, and EpiLUTS) demonstrated this interconnec-
tion [15]. However, those studies all included participants from 
only the general population. Diagnoses of depression were nei-
ther established nor confirmed by psychiatrists. The results 
were based solely on single, sometimes nonstandard instru-
ments to assess depression. The measures used in studies that 
focused on the general population were used only to screen for 
depression, and they were not diagnostic even if they were ef-
fective in assessing symptom load [28]. Therefore, all these ear-
lier studies, in fact, analyzed correlations between sleep quality 
and OAB in the general population or, at best, in patients with 
depressive symptoms, but not necessarily depression. Until 
impact of OAB symptoms on sleep quality in a unique patient 
population reliably diagnosed with, and treated for, depression. 
Almost 13% of patients with our depression in our cohort 
reached the diagnostic threshold of OAB using the validated 
ICIQ-OAB instrument. Thus, OAB symptoms may be present 
in a substantial percentage of patients with depression receiving 
routine psychiatric treatment. Further, sleep quality analyzed 
with 2 independent validated questionnaires (i.e., the HSDQ 
and AIS) was correlated with OAB. These disorders and symp-
toms tended to coexist and likely compounded the severity of 
each another. This coexistence property should prompt a re‐
evaluation of current recommendations on diagnosis of sleep 
problems for patients with depression [22,23]. Depressed pa-
tients, primarily those reporting sleep problems, should be 
screened carefully for OAB symptoms. Psychiatrists may have 
limited perception of lower urinary tract symptoms, including 
OAB, in their patient populations [24]; thus, complex manage-
Table 6. Regression analysis of the effect of depression severity 
and OAB symptoms assessed with the ICIQ-OAB on sleep 












Remission/no depression (0–7) 0.0119
Mild depression (8–16) 0.2123
Moderate depression (17–23) 0.2780






OAB, overactive bladder; ICIQ-OAB, International Consultation on In-
continence Questionnaire Overactive Bladder Module; HRSD, Hamil-
ton Rating Scale for Depression.
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now, it was questionable whether any relationship exists be-
tween OAB symptoms, sleep quality, and reliably diagnosed de-
pression. Our study has established this relationship.
Nocturia needs special consideration. Studies of the general 
population showed that 2 episodes of nocturia is a threshold for 
bother [29]. One nightly void did not appear to be sufficiently 
disruptive to cause significant bother for most patients. Howev-
er, this 2-episode threshold is not recommended for all patient 
populations [29]. In our study, at least 3 episodes of nocturia 
were necessary to significantly lower sleep quality in individuals 
with depression. We speculate that patients with depression 
have a greater tolerance for nocturia. We also found that noctu-
ria may not be the only significant predictor of sleep distur-
bances because other OAB symptoms also contributed to im-
paired sleep patterns.
The pathophysiology responsible for the negative effects of 
OAB on sleep quality is not well understood. First, nocturia, an 
OAB symptom, substantially deteriorates sleep quality. Noctu-
ria-induced sleep fragmentation causes daytime drowsiness, 
poor concentration, and anxiety, which leads to impaired occu-
pational functioning and physical and emotional health, ulti-
mately degrading an individual’s quality of life [30]. Second, ob-
structive sleep apnea, a disorder with repeated episodes of com-
plete or partial obstruction of the upper airway during sleep, 
was also linked to OAB (mainly to nocturia and urgency) and 
poor sleep quality [31]. Obstructive sleep apnea may lead to in-
creased secretion of atrial natriuretic peptide in response to air-
way obstruction, thereby causing nocturnal polyuria. Animal 
studies also showed that hypoxia induced by obstructive sleep 
apnea was associated with bladder oxidative stress, altered cell 
signaling, and structural damage, finally leading to increased 
urinary frequency and involuntary bladder contractions [32]. 
Notably, in our cohort, no patient was diagnosed with obstruc-
tive sleep apnea. Third, another hypothesis is that central sensi-
tization with spinal hypersensitivity may lead to a variety of 
chronic pain disorders that share some pathophysiological 
pathways with OAB [33]. Finally, the increased presence of 
non-urologic symptoms in OAB patients suggests an underly-
ing systemic etiology and pathogenetic mechanisms that may 
contribute to OAB. Differences have been observed between 
OAB and non-OAB patients across multiple organ systems, in-
cluding neurological, cardiopulmonary, gastrointestinal, sexual, 
musculoskeletal, and gynecological systems [34]. About a third 
of OAB patients report widespread systemic symptoms, with a 
high symptom burden across multiple organ systems [34]. This 
multiorgan involvement suggests that correlation between OAB 
symptoms and sleep quality may be more complex than ex-
pected.
There are some potential weaknesses of our study. First, pa-
tients were not reliably diagnosed with OAB. An accurate diag-
nosis of OAB requires exclusion of urinary tract infection or 
other obvious pathologies. In addition, we did not collect data 
from voiding diaries. However, we assessed OAB symptoms us-
ing an instrument with an adequate threshold score that has 
been validated in other OAB studies. Second, we focused on 
the continuous variable of general sleep disorder from the 
HSDQ. We attempted to perform correlation analyses for each 
of the questionnaire clusters, which may have further differenti-
ated various types of sleep disorders; however, using the HSDQ 
we were not able to identify consistent relationships between 
specific types of sleep disorders and OAB. Although our sample 
size was large enough for a powerful statistical analysis, the 
study may have lacked adequate power for specific and detailed 
analyses. Third, we were not able to longitudinally assess our 
patients. It is an open question whether OAB-specific treat-
ments, including physiotherapy, patient education, and phar-
macotherapy, would improve sleep quality in this specific pa-
tient group. In the general population, sleep quality improved 
after OAB therapies such as anticholinergics or sacral neuro-
modulation [35]. Nonetheless, we used data obtained from a 
prospectively maintained database. Finally, we acknowledge 
that the patients evaluated were a highly selected cohort, treated 
at a single, high-volume academic center; our findings could 
have been somewhat different if we had assessed a less highly 
selected cohort of patients treated for depression.
In conclusion, this study of a carefully constructed cohort has 
shown a link between OAB symptoms in patients with depres-
sion and sleep quality. OAB symptoms were present in a sub-
stantial percentage of our cohort of patients who had been di-
agnosed with, and were receiving treatment for, depression. We 
also found a strong correlation between OAB symptoms and 
sleep quality. Therefore, healthcare professionals who treat pa-
tients with depression should screen for both sleep problems 
and OAB symptoms. We suggest that our study will promote 
improved patient-centered care of individuals with depression.
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